| Fair Value Disclosures |
8. Fair Value Disclosures
Fair Value Hierarchy
Assets and liabilities measured at fair value on a recurring basis
|
March 31, 2022
(in millions) |
Quoted Prices in
Active
Markets for
Identical Assets
(Level 1) |
|
|
Significant Other
Observable Inputs
(Level 2) |
|
|
Significant
Unobservable
Inputs
(Level 3) |
|
|
Investments
Measured at
NAV(1) |
|
|
Other(2) |
|
|
March 31,
2022 |
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-to-maturity investments |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
460 |
|
|
$ |
460 |
|
|
Trading securities |
|
— |
|
|
|
1,124 |
|
|
|
8 |
|
|
|
— |
|
|
|
— |
|
|
|
1,132 |
|
|
Total debt securities |
|
— |
|
|
|
1,124 |
|
|
|
8 |
|
|
|
— |
|
|
|
460 |
|
|
|
1,592 |
|
|
Equity securities at FVTNI: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities/mutual funds |
|
1,769 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,769 |
|
|
Equity method: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity and fixed income mutual funds |
|
261 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
261 |
|
|
Hedge funds/funds of hedge funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
433 |
|
|
|
— |
|
|
|
433 |
|
|
Private equity funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
847 |
|
|
|
— |
|
|
|
847 |
|
|
Real assets funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
256 |
|
|
|
— |
|
|
|
256 |
|
|
Total equity method |
|
261 |
|
|
|
— |
|
|
|
— |
|
|
|
1,536 |
|
|
|
— |
|
|
|
1,797 |
|
|
Bank loans |
|
— |
|
|
|
28 |
|
|
|
264 |
|
|
|
— |
|
|
|
— |
|
|
|
292 |
|
|
Federal Reserve Bank Stock |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
96 |
|
|
|
96 |
|
|
Carried interest |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,778 |
|
|
|
1,778 |
|
|
Other investments(3) |
|
— |
|
|
|
12 |
|
|
|
4 |
|
|
|
95 |
|
|
|
180 |
|
|
|
291 |
|
|
Total investments |
|
2,030 |
|
|
|
1,164 |
|
|
|
276 |
|
|
|
1,631 |
|
|
|
2,514 |
|
|
|
7,615 |
|
|
Other assets(4) |
|
181 |
|
|
|
19 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
200 |
|
|
Separate account assets |
|
48,288 |
|
|
|
26,271 |
|
|
|
— |
|
|
|
— |
|
|
|
794 |
|
|
|
75,353 |
|
|
Separate account collateral held under
securities lending agreements: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities |
|
2,903 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,903 |
|
|
Debt securities |
|
— |
|
|
|
4,180 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,180 |
|
|
Total separate account collateral held under
securities lending agreements |
|
2,903 |
|
|
|
4,180 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
7,083 |
|
|
Total |
$ |
53,402 |
|
|
$ |
31,634 |
|
|
$ |
276 |
|
|
$ |
1,631 |
|
|
$ |
3,308 |
|
|
$ |
90,251 |
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate account collateral liabilities under
securities lending agreements |
$ |
2,903 |
|
|
$ |
4,180 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,083 |
|
|
Other liabilities(5) |
|
— |
|
|
|
35 |
|
|
|
312 |
|
|
|
— |
|
|
|
— |
|
|
|
347 |
|
|
Total |
$ |
2,903 |
|
|
$ |
4,215 |
|
|
$ |
312 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,430 |
|
|
(1) |
Amounts are comprised of certain investments measured at fair value using NAV (or its equivalent) as a practical expedient. |
|
(2) |
Amounts are comprised of investments held at amortized cost and cost, adjusted for observable price changes, carried interest and certain equity method investments, which include sponsored investment funds and other assets, which are not accounted for under a fair value measure. In accordance with GAAP, certain equity method investees do not account for both their financial assets and liabilities under fair value measures; therefore, the Company’s investment in such equity method investees may not represent fair value. |
|
(3) |
Level 3 amounts primarily include direct investments in private equity companies held by consolidated private equity funds. |
|
(4) |
Level 1 amount includes a minority investment in a publicly traded company. |
|
(5) |
Level 2 amount primarily includes fair value of derivatives (See Note 9, Derivatives and Hedging, for more information). Level 3 amounts primarily include borrowings of a consolidated CLO classified based on the significance of unobservable inputs used for calculating the fair value of consolidated CLO assets, and contingent liabilities related to certain acquisitions (see Note 15, Commitments and Contingencies, for more information). |
Assets and liabilities measured at fair value on a recurring basis
|
December 31, 2021
(in millions) |
Quoted Prices in
Active
Markets for
Identical Assets
(Level 1) |
|
|
Significant Other
Observable Inputs
(Level 2) |
|
|
Significant
Unobservable
Inputs
(Level 3) |
|
|
Investments
Measured at
NAV(1) |
|
|
Other(2) |
|
|
December 31,
2021 |
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Held-to-maturity investments |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
430 |
|
|
$ |
430 |
|
|
Trading securities |
|
— |
|
|
|
1,169 |
|
|
|
17 |
|
|
|
— |
|
|
|
— |
|
|
|
1,186 |
|
|
Total debt securities |
|
— |
|
|
|
1,169 |
|
|
|
17 |
|
|
|
— |
|
|
|
430 |
|
|
|
1,616 |
|
|
Equity securities at FVTNI: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities/mutual funds |
|
1,738 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,738 |
|
|
Equity method: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity and fixed income mutual funds |
|
245 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
245 |
|
|
Hedge funds/funds of hedge funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
369 |
|
|
|
— |
|
|
|
369 |
|
|
Private equity funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
846 |
|
|
|
— |
|
|
|
846 |
|
|
Real assets funds |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
234 |
|
|
|
— |
|
|
|
234 |
|
|
Total equity method |
|
245 |
|
|
|
— |
|
|
|
— |
|
|
|
1,449 |
|
|
|
— |
|
|
|
1,694 |
|
|
Bank loans |
|
— |
|
|
|
14 |
|
|
|
270 |
|
|
|
— |
|
|
|
— |
|
|
|
284 |
|
|
Federal Reserve Bank Stock |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
96 |
|
|
|
96 |
|
|
Carried interest |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,555 |
|
|
|
1,555 |
|
|
Other investments(3) |
|
— |
|
|
|
— |
|
|
|
5 |
|
|
|
96 |
|
|
|
178 |
|
|
|
279 |
|
|
Total investments |
|
1,983 |
|
|
|
1,183 |
|
|
|
292 |
|
|
|
1,545 |
|
|
|
2,259 |
|
|
|
7,262 |
|
|
Other assets(4) |
|
195 |
|
|
|
39 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
234 |
|
|
Separate account assets |
|
54,675 |
|
|
|
30,786 |
|
|
|
— |
|
|
|
— |
|
|
|
765 |
|
|
|
86,226 |
|
|
Separate account collateral held under
securities lending agreements: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities |
|
3,717 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,717 |
|
|
Debt securities |
|
— |
|
|
|
3,364 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,364 |
|
|
Total separate account collateral held under
securities lending agreements |
|
3,717 |
|
|
|
3,364 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
7,081 |
|
|
Total |
$ |
60,570 |
|
|
$ |
35,372 |
|
|
$ |
292 |
|
|
$ |
1,545 |
|
|
$ |
3,024 |
|
|
$ |
100,803 |
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separate account collateral liabilities under
securities lending agreements |
$ |
3,717 |
|
|
$ |
3,364 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,081 |
|
|
Other liabilities(5) |
|
— |
|
|
|
26 |
|
|
|
342 |
|
|
|
— |
|
|
|
— |
|
|
|
368 |
|
|
Total |
$ |
3,717 |
|
|
$ |
3,390 |
|
|
$ |
342 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
7,449 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Amounts are comprised of certain investments measured at fair value using NAV (or its equivalent) as a practical expedient. |
|
(2) |
Amounts are comprised of investments held at amortized cost and cost, adjusted for observable price changes, carried interest and certain equity method investments, which include sponsored investment funds and other assets, which are not accounted for under a fair value measure. In accordance with GAAP, certain equity method investees do not account for both their financial assets and liabilities under fair value measures; therefore, the Company’s investment in such equity method investees may not represent fair value. |
|
(3) |
Level 3 amounts include direct investments in private equity companies held by consolidated private equity funds. |
|
(4) |
Level 1 amount includes a minority investment in a publicly traded company. |
|
(5) |
Level 2 amount primarily includes fair value of derivatives (See Note 9, Derivatives and Hedging, for more information). Level 3 amounts primarily include borrowings of a consolidated CLO classified based on the significance of unobservable inputs used for calculating the fair value of consolidated CLO assets, and contingent liabilities related to certain acquisitions (see Note 15, Commitments and Contingencies, for more information). |
Level 3 Assets. Level 3 assets may include investments in CLOs and bank loans of consolidated CLOs, which were valued based on single-broker nonbinding quotes and direct private equity investments, which were valued using the market or income approach.
Level 3 investments of $276 million and $292 million at March 31, 2022 and December 31, 2021, respectively, primarily included bank loans of a consolidated CLO.
Level 3 Liabilities. Level 3 liabilities primarily include borrowings of a consolidated CLO, which were valued based on the fair value of the assets of the consolidated CLO less the fair value of the Company’s economic interest in the CLO, and contingent liabilities related to certain acquisitions, which were valued based upon discounted cash flow analyses using unobservable market data inputs.
Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis for the Three Months Ended March 31, 2022
|
(in millions) |
|
December 31,
2021 |
|
|
Realized
and
Unrealized
Gains
(Losses) |
|
|
Purchases |
|
|
Sales and
Maturities |
|
|
Issuances and
other
Settlements(1) |
|
|
Transfers
into
Level 3 |
|
|
Transfers
out of
Level 3 |
|
|
March 31,
2022 |
|
|
Total Net
Unrealized
Gains (Losses)
Included in
Earnings(2) |
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading |
|
$ |
17 |
|
|
$ |
— |
|
|
$ |
6 |
|
|
$ |
(12 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(3 |
) |
|
$ |
8 |
|
|
$ |
— |
|
|
Total debt securities |
|
|
17 |
|
|
|
— |
|
|
|
6 |
|
|
|
(12 |
) |
|
|
— |
|
|
|
— |
|
|
|
(3 |
) |
|
|
8 |
|
|
|
— |
|
|
Private equity |
|
|
5 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1 |
) |
|
|
4 |
|
|
|
— |
|
|
Bank loans |
|
|
270 |
|
|
|
— |
|
|
|
8 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(14 |
) |
|
|
264 |
|
|
|
— |
|
|
Total investments |
|
|
292 |
|
|
|
— |
|
|
|
14 |
|
|
|
(12 |
) |
|
|
— |
|
|
|
— |
|
|
|
(18 |
) |
|
|
276 |
|
|
|
— |
|
|
Total Level 3 assets |
|
$ |
292 |
|
|
$ |
— |
|
|
$ |
14 |
|
|
$ |
(12 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(18 |
) |
|
$ |
276 |
|
|
$ |
— |
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities |
|
$ |
342 |
|
|
$ |
(1 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(31 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
312 |
|
|
$ |
(1 |
) |
|
Total Level 3 liabilities |
|
$ |
342 |
|
|
$ |
(1 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(31 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
312 |
|
|
$ |
(1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Amounts primarily include contingent liability payments related to certain acquisitions. |
|
(2) |
Earnings attributable to the change in unrealized gains (losses) relating to assets and liabilities still held at the reporting date. |
Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis for the Three Months Ended March 31, 2021
|
(in millions) |
|
December 31,
2020 |
|
|
Realized
and
Unrealized
Gains
(Losses) |
|
|
Purchases |
|
|
Sales and
Maturities |
|
|
Issuances and
other
Settlements(1) |
|
|
Transfers
into
Level 3 |
|
|
Transfers
out of
Level 3 |
|
|
March 31,
2021 |
|
|
Total Net
Unrealized
Gains (Losses)
Included in
Earnings(2) |
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading |
|
$ |
11 |
|
|
$ |
— |
|
|
$ |
5 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(2 |
) |
|
$ |
14 |
|
|
$ |
— |
|
|
Total debt securities |
|
|
11 |
|
|
|
— |
|
|
|
5 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2 |
) |
|
|
14 |
|
|
|
— |
|
|
Private equity |
|
|
9 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
9 |
|
|
|
— |
|
|
Bank loans |
|
|
232 |
|
|
|
— |
|
|
|
9 |
|
|
|
— |
|
|
|
— |
|
|
|
4 |
|
|
|
(10 |
) |
|
|
235 |
|
|
|
— |
|
|
Total investments |
|
$ |
252 |
|
|
$ |
— |
|
|
$ |
14 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4 |
|
|
$ |
(12 |
) |
|
$ |
258 |
|
|
$ |
— |
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities |
|
$ |
272 |
|
|
$ |
(3 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
5 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
280 |
|
|
$ |
(3 |
) |
|
Total Level 3 liabilities |
|
$ |
272 |
|
|
$ |
(3 |
) |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
5 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
280 |
|
|
$ |
(3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Amounts include proceeds from borrowings of a consolidated CLO and contingent liability payment related to a prior acquisition. |
|
(2) |
Earnings attributable to the change in unrealized gains (losses) relating to assets and liabilities still held at the reporting date. |
Realized and Unrealized Gains (Losses) for Level 3 Assets and Liabilities. Realized and unrealized gains (losses) recorded for Level 3 assets and liabilities are reported in nonoperating income (expense) on the condensed consolidated statements of income. A portion of net income (loss) for consolidated sponsored investment funds is allocated to NCI to reflect net income (loss) not attributable to the Company.
Transfers in and/or out of Levels. Transfers in and/or out of levels are reflected when significant inputs, including market inputs or performance attributes, used for the fair value measurement become observable/unobservable, or when the carrying value of certain equity method investments no longer represents fair value as determined under valuation methodologies.
Disclosures of Fair Value for Financial Instruments Not Held at Fair Value. At March 31, 2022 and December 31, 2021, the fair value of the Company’s financial instruments not held at fair value are categorized in the table below:
|
|
March 31, 2022 |
|
|
December 31, 2021 |
|
|
|
|
|
(in millions) |
Carrying
Amount |
|
|
Estimated
Fair Value |
|
|
Carrying
Amount |
|
|
Estimated
Fair Value |
|
|
Fair Value
Hierarchy |
|
|
Financial Assets(1): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
7,262 |
|
|
$ |
7,262 |
|
|
$ |
9,323 |
|
|
$ |
9,323 |
|
|
Level 1 |
(2) (3) |
|
Other assets |
$ |
29 |
|
|
$ |
29 |
|
|
$ |
22 |
|
|
$ |
22 |
|
|
Level 1 |
(2) (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term borrowings |
$ |
7,430 |
|
|
$ |
7,253 |
|
|
$ |
7,446 |
|
|
$ |
7,735 |
|
|
Level 2 |
(5) |
|
(1) |
See Note 5, Investments, for further information on investments not held at fair value. |
|
(2) |
Cash and cash equivalents are carried at either cost or amortized cost, which approximates fair value due to their short-term maturities. |
|
(3) |
At March 31, 2022 and December 31, 2021, approximately $1.7 billion and $2.4 billion, respectively, of money market funds were recorded within cash and cash equivalents on the condensed consolidated statements of financial condition. Money market funds are valued based on quoted market prices, or $1.00 per share, which generally is the NAV of the fund. |
|
(4) |
Other assets include restricted cash and cash collateral deposited with certain derivative counterparties. |
|
(5) |
Long-term borrowings are recorded at amortized cost, net of debt issuance costs. The fair value of the long-term borrowings, including the current portion of long-term borrowings, is determined using market prices and the EUR/USD foreign exchange rate at the end of March 2022 and December 2021, respectively. See Note 14, Borrowings, for the fair value of each of the Company’s long-term borrowings. |
Investments in Certain Entities that Calculate NAV Per Share
As a practical expedient to value certain investments that do not have a readily determinable fair value and have attributes of an investment company, the Company uses NAV as the fair value. The following tables list information regarding all investments that use a fair value measurement to account for both their financial assets and financial liabilities in their calculation of a NAV per share (or equivalent).
|
March 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
Ref |
|
Fair Value |
|
|
Total
Unfunded
Commitments |
|
|
Redemption
Frequency |
|
Redemption
Notice Period |
|
Equity method:(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hedge funds/funds of hedge funds |
|
(a) |
|
$ |
433 |
|
|
$ |
113 |
|
|
Daily/Monthly (20%)
Quarterly (13%)
N/R (67%) |
|
1 – 90 days |
|
Private equity funds |
|
(b) |
|
|
847 |
|
|
|
188 |
|
|
N/R |
|
N/R |
|
Real assets funds |
|
(c) |
|
|
256 |
|
|
|
260 |
|
|
Quarterly (18%)
N/R (82%) |
|
60 days |
|
Consolidated sponsored investment
products: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real assets funds |
|
(d) |
|
|
89 |
|
|
|
95 |
|
|
N/R |
|
N/R |
|
Other funds |
|
(c) |
|
|
6 |
|
|
|
24 |
|
|
N/R |
|
N/R |
|
Total |
|
|
|
$ |
1,631 |
|
|
$ |
680 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
Ref |
|
Fair Value |
|
|
Total
Unfunded
Commitments |
|
|
Redemption
Frequency |
|
Redemption
Notice Period |
|
Equity method:(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hedge funds/funds of hedge funds |
|
(a) |
|
$ |
369 |
|
|
$ |
141 |
|
|
Daily/Monthly (20%)
Quarterly (20%)
N/R (60%) |
|
1 – 90 days |
|
Private equity funds |
|
(b) |
|
|
846 |
|
|
|
153 |
|
|
N/R |
|
N/R |
|
Real assets funds |
|
(c) |
|
|
234 |
|
|
|
245 |
|
|
Quarterly (20%)
N/R (80%) |
|
60 days |
|
Consolidated sponsored investment
products: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real assets funds |
|
(d) |
|
|
90 |
|
|
|
101 |
|
|
N/R |
|
N/R |
|
Other funds |
|
(c) |
|
|
6 |
|
|
|
25 |
|
|
N/R |
|
N/R |
|
Total |
|
|
|
$ |
1,545 |
|
|
$ |
665 |
|
|
|
|
|
N/R – not redeemable
|
(1) |
Comprised of equity method investments, which include investment companies, that account for their financial assets and most financial liabilities under fair value measures; therefore, the Company’s investment in such equity method investees approximates fair value. |
|
(a) |
This category includes hedge funds and funds of hedge funds that invest primarily in equities, fixed income securities, distressed credit, opportunistic and mortgage instruments and other third-party hedge funds. The fair values of the investments have been estimated using the NAV of the Company’s ownership interest in partners’ capital. The liquidation period for the investments in the funds that are not subject to redemption is unknown at both March 31, 2022 and December 31, 2021. |
|
(b) |
This category includes private equity funds that initially invest in nonmarketable securities of private companies, which ultimately may become public in the future. The fair values of these investments have been estimated using capital accounts representing the Company’s ownership interest in the funds as well as other performance inputs. The Company’s investment in each fund is not subject to redemption and is normally returned through distributions as a result of the liquidation of the underlying assets of the private equity funds. The liquidation period for the investments in these funds is unknown at both March 31, 2022 and December 31, 2021. |
|
(c) |
This category includes several real assets funds that invest directly and indirectly in real estate or infrastructure. The fair values of the investments have been estimated using capital accounts representing the Company’s ownership interest in the funds. The Company’s investments that are not subject to redemption or are not currently redeemable are normally returned through distributions and realizations of the underlying assets of the funds. The liquidation period for the investments in the funds that are not subject to redemptions is unknown at both March 31, 2022 and December 31, 2021. The total remaining unfunded commitments to real assets funds were $355 million and $346 million at March 31, 2022 and December 31, 2021, respectively. The Company’s portion of the total remaining unfunded commitments was $309 million and $298 million at March 31, 2022 and December 31, 2021, respectively. |
|
(d) |
This category includes the underlying third-party private equity funds within consolidated BlackRock sponsored private equity funds of funds. These investments are not subject to redemption or are not currently redeemable; however, for certain funds, the Company may sell or transfer its interest, which may need approval by the general partner of the underlying funds. Due to the nature of the investments in this category, the Company reduces its investment by distributions that are received through the realization of the underlying assets of the funds. The liquidation period for the underlying assets of these funds is unknown. |
Fair Value Option
At March 31, 2022 and December 31, 2021, the Company elected the fair value option for certain investments in CLOs of approximately $39 million and $47 million, respectively, reported within investments.
In addition, the Company elected the fair value option for bank loans and borrowings of a consolidated CLO, recorded within investments and other liabilities, respectively. The following table summarizes the information related to these bank loans and borrowings at March 31, 2022 and December 31, 2021:
|
|
|
March 31, |
|
|
December 31, |
|
|
(in millions) |
|
2022 |
|
|
2021 |
|
|
CLO Bank loans: |
|
|
|
|
|
|
|
|
|
Aggregate principal amounts outstanding |
|
$ |
291 |
|
|
$ |
281 |
|
|
Fair value |
|
|
292 |
|
|
|
284 |
|
|
Aggregate unpaid principal balance in excess of (less than) fair value |
|
$ |
(1 |
) |
|
$ |
(3 |
) |
|
|
|
|
|
|
|
|
|
|
|
CLO Borrowings: |
|
|
|
|
|
|
|
|
|
Aggregate principal amounts outstanding |
|
$ |
275 |
|
|
$ |
275 |
|
|
Fair value |
|
$ |
277 |
|
|
$ |
278 |
|
At March 31, 2022, the principal amounts outstanding of the borrowings issued by the CLOs mature in 2030.
During the three months ended March 31, 2022 and 2021, the net gains (losses) from the change in fair value of the bank loans and borrowings held by the consolidated CLO were not material and were recorded in net gain (loss) on the condensed consolidated statements of income. The change in fair value of the assets and liabilities included interest income and expense, respectively.
|